We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: Changsha high-tech development zone, 100 foot cloud road brought science park 14 layer 5, 501
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no
Payment Terms: L/L
Salinomycin is a new kind of chicken with ball insect proof agent, piglets and fattening pig growth promoters. Ec approved in 1987, in 1993 China's ministry of agriculture approval to use. It belongs to a new generation of ionic growth promoting agent, the main effect is by interfering with harmful microbial growth, effective control of diarrhea morbidity and mortality, improve digestion and absorption of nutrients, guarantee and promote the healthy growth of livestock and poultry, improve the feed conversion rate, improve the economic benefit.
Items
Specification
Results
Appearance
yellow-brownish granules
yellow-brownish granules
Identification
Ethanol solution of the substance to be examined reacting with vanillin test solution shows red
Positive Reaction
Particle size
≥95% pass through a 24 mesh sieve
100%
Loss on drying
≤8.0%
0.50%
Heavy metals
≤0.0020%
<0.0002%
Arsenic
≤0.0002%
<0.0002%
Salinomycin A
>85.0%
FILL
THE AVERAGE FILL IS NOT LESS
THAN THE LABELED FILL AND
FILL OF EACH CONTAINER IS NOT
LESS THAN 98% OF THE LABELED
FILL
Ten years of qualification
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
